"Vaccine and Drug Development Strategies with Computational Methods" within the scope of "Scientific Response Against Covid-19" project
3rd Information Day Scope
The third information day is being organized to introduce the innovations brought by computational biology and artificial intelligence technologies, which gained momentum with the COVID-19 pandemic, to vaccine and drug development processes, within the scope of the "Scientific Response Against Covid-19" project carried out under the Competitive Sectors Programme financed by the European Union and Republic of Turkey financial cooperation and conducted by the Ministry of Industry and Technology. During the pandemic process, rapid and innovative solutions needed to be found in the field of drug and vaccine development; this has significantly increased the importance and use of computational methods. Computational modeling, simulation techniques, and artificial intelligence applications have played an important role in many critical stages, from structural analysis of virus proteins to identification of effective drug molecules. Within the scope of the event, it will be discussed how these technologies accelerate research and development processes and provide more effective solutions.
Particularly artificial intelligence and machine learning have enabled rapid understanding of the virus structure and identification of potential treatment options in the fight against COVID-19. These technologies have made vaccine and drug development processes more efficient by analyzing large biomedical datasets. At the same time, computational tools evaluating the potential use of existing drugs for new diseases like COVID-19 have enabled the acceleration of clinical processes and rapid implementation of treatment strategies. Structural biology and simulation techniques have guided the design of effective vaccines by identifying antigenic regions of COVID-19's spike proteins.
This event aims to share innovative solutions provided by computational methods in health crises and future research opportunities with participants. Computational biology and artificial intelligence have transformed healthcare technologies by increasing speed and accuracy in drug and vaccine development processes in response to the challenges brought by the pandemic; it provides an important platform to share the most current developments in these fields.
